| CODE |
TEST NAME |
FILE DATE |
| BLOD0330 |
Hepatitis A Total Antibody (HAVAb)
by Chemiluminometric Immunoassay
*Detects past and/or acute infections or immunization of Hepatitis A, but does not distinguish between IgG or IgM antibodies. |
2-1-2012 |
| BLOD0340 |
Hepatitis Be Antigen (HBeAg)
by Immunoassay
*Detects acute active Hepatitis B virus infection. |
2-1-2012 |
| BLOD0329 |
Hepatitis Be Antibody (HBeAb)
by Immunoassay
*Used in the differential diagnosis, staging, and prognosis of Hepatitis B infection. HBeAB appears in the early convalescence of Hepatitis B Virus infection. |
2-1-2012 |
| BLOD0793 |
PTH Intact + Calcium
by Chemiluminescence
*Includes Total Calcium
**The Intact (ICMA) PTH is the recommended initial assay for the differential diagnosis of calcium-related abnormalities. |
2-1-2012 |
| NBLD0422 |
Lactoferrin Screen Stool
by Immunochromatographic Assay
*Used for the qualitative detection of elevated levels of stool lactoferrin |
2-1-2012 |
| NBLD0423 |
Lactoferrin Quantitative Stool
by Enzyme-Linked Immunosorbent Assay
*Used for the quantitative measurement of lactoferrin concentration in stool |
2-1-2012 |
| BLOD0206 |
Serotonin (5-HIAA)
by HPLC |
2-1-2012 |
| BLOD0003 |
Acetone (Blood Ketone), Quantitative
by Colorimetric |
2-1-2012 |
| NBLD0421 |
Lamellar Body Count
*It is used for predicting and assessing the risk of developing neonatal respiratory distress syndrome (RDS) when performed during 32 to 39 weeks gestation. |
2-1-2012 |
| BLOD0342 |
Hepatitis C Virus RNA Qualitative
by RT-PCR |
2-1-2012 |
| NBLD0326 |
Chromosome Study for Hematologic Malignancy Bone Marrow
|
2-1-2012 |
| NBLD0371 |
Respiratory DFA Comprehensive 2 with Reflex to Viral Culture
by DFA |
2-1-2012 |
| NBLD0255 |
Respiratory DFA Comprehensive 1 with Reflex to Viral Culture
|
2-1-2012 |
| BLOD1009 |
Vitamin E (Tocopherol)
by HPLC
*Reported as Alpha-tocopherol and Beta-gammatocopherol |
2-1-2012 |
| BLOD0371 |
von Willebrand Workup
*Includes:
-Coagulation Factor VIII Activity Assay
-von Willebrand Factor Antigen
-von Willebrand Factor Activity
**Special coagulation interpretation with possible reflex to Coagulation Factor VIII Assay Inhibitor Screen; Ristocetin Cofactor; von Willebrand Factor Multimer; and Bethesda titer
- all performed at an additional fee. |
2-1-2012 |
| BLOD0171 |
Vitamin D 1,25 dihydroxy Serum
by Liquid Chromatography/Tandem Mass Spectrometry
*Note: Reports Total, D2, and D3 of 1,25 Dihydroxyvitamin D; measures the bio-active form of Vitamin D. |
2-1-2012 |
| BLOD0409 |
Vitamin D 25-hydroxy Total
by Chemilluminescence Immunoassay
*This assay tests for both Vitamin D2 and D3 but does not differentiate. |
2-1-2012 |
| NBLD0297 |
Urovysion Bladder Cancer FISH
by Fluorescence In Situ Hybridization (FISH)
*FISH analysis of urothelial cells from urine samples may be used to monitor patients with a history of urothelial carcinomas for disease recurrence. |
2-1-2012 |
| NBLD0196 |
Urinalysis Macroscopic Reflex to Microscopic Exam
by Dipstick, Automated |
2-1-2012 |
| NBLD0194 |
Urinalysis Complete Reflex to Culture
by Dipstick, Microscopy, and Culture if Indicated |
2-1-2012 |
| BLOD0189 |
Tryptase Total
by Fluorescence Enzyme Immunoassay
*This test includes alpha and beta tryptase which is reported as total tryptase. |
2-1-2012 |
| BLOD0018 |
Tranxene (Clorazepate)
by HPLC
*Measured as metabolite Desmethyldiazepam |
2-1-2012 |
| BLOD0106 |
Thyrotropin Receptor Antibody (TRAb)
by Electrochemiluminescence Immunoassay
*This test is used to evaluated patients suspected of Graves Disease. |
2-1-2012 |
| BLOD0414 |
Testosterone Total and Free
by Liquid Chromatography Tandem Mass (LC/MS/MS), Equilibrium Dialysis
*This test includes pediatric reference ranges and tanner stages. |
2-1-2012 |
| BLOD0385 |
Sinequan (Doxepin)
by HPLC-UV
*Includes metabolite Desmethyldoxepin (Nordoxepin) |
2-1-2012 |
| NBLD0234 |
Strep Group A Rapid
Screen Reflex to Confirmation
*If negative, a culture is performed at an additional fee. |
2-1-2012 |
| BLOD0671 |
Sickle Cell Screen
*Positives should be followed by Hemoglobin Electrophoresis. |
2-1-2012 |
| NBLD0229 |
RSV (Respiratory Syncytial Virus) Rapid
by Rapid Immunochromatographic
*This methodology is approved for patients 0-5 years old only |
2-1-2012 |
| BLOD0493 |
Rickettsial IgG and IgM Antibodies
by IFA
*Includes Rocky Mountain Spotted Fever and Murine Typhus |
2-1-2012 |
| NBLD0012 |
Rohypnol (Flunitrazepam) Urine
by IA, GC/MS
*Specimens screened by Immunoassay at a threshold concentration of 100 ng/mL. Any positive is confirmed by GC/MS. |
2-1-2012 |
| BLOD1027 |
Reticulocyte Hemoglobin Content (CHr)
by Flow Cytometry
*Includes a Reticulocyte Count and Reticulocyte Hemoglobin |
2-1-2012 |
| NBLD0229 |
Respiratory Syncytial Virus (RSV) Rapid
by Rapid Immunochromatographic
*This methodology is approved for patients 0-5 years old only. |
2-1-2012 |
| NBLD0376 |
Respiratory PCR Panel with Reflex
by Real Time PCR
*Negative reflexes to Respiratory DFA 2 Battery. |
2-1-2012 |
| NBLD0375 |
Respiratory PCR Panel
by Real-Time PCR |
2-1-2012 |
| BLOD0769 |
Respiratory Disease Allergy Panel + Total IgE
Central Midwest States
by Fluoroallergrosorbent, Fluoroenzymeimmunoassay
*For upper and lower respiratory disease.
**Recommended for persons 4 and older. |
2-1-2012 |
| BLOD1072 |
Respiratory Disease Western Allergy Panel + Total IgE
Western South Dakota
by Fluoroallergrosorbent, Fluoroenzymeimmunoassay
*For upper and lower respiratory disease |
2-1-2012 |
| NBLD0234 |
Rapid Strep Group A Reflex to Confirmation
*If negative, a culture is performed at an additional fee. |
2-1-2012 |
| BLOD0466 |
Q Fever Antibodies IgG IgM and IgA (Coxiella burnetti)
by IFA
*Includes Phase I and Phase II of IgG, IgM, & IgA |
2-1-2012 |
| BLOD0594 |
PSA (Prostate Specific Antigen) Total
by Electrochemiluminescence Immunoassay (ECLIA) - Rapid City
by Chemiluminescence - Sioux Falls
*Diagnostic and Non-Medicare Screening |
2-1-2012 |
| BLOD0163 |
Pseudocholinesterase Plasma
by Kinetic/Spectrophotometric
*Use for preanesthesia testing and monitoring pesticide/organophosphate exposure. |
2-1-2012 |
